Q1 2020 13F Holders as of 3/31/2020
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
652
-
Total shares
-
47M
-
Shares change
-
-6.42M
-
Total reported value, excl. options
-
$5.06B
-
Value change
-
-$725M
-
Put/Call ratio
-
2.03
-
Number of buys
-
238
-
Number of sells
-
-354
-
Price
-
$107.74
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q1 2020
679 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q1 2020.
ISHARES TR - ISHARES BIOTECH (IBB) has 652 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 47M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (13.8M shares), MORGAN STANLEY (5.6M shares), GOLDMAN SACHS GROUP INC (4.14M shares), BARCLAYS PLC (3.06M shares), CITIGROUP INC (2.16M shares), UBS Group AG (1.83M shares), JPMORGAN CHASE & CO (1.4M shares), BNP PARIBAS ARBITRAGE, SA (987K shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (940K shares), and ROYAL BANK OF CANADA (614K shares).
This table shows the top 652 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.